Genetic variation in 11β-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome

被引:68
作者
Gambineri, Alessandra
Vicennati, Valentina
Genghini, Silvia
Tomassoni, Federica
Pagotto, Uberto
Pasquali, Renato
Walker, Brian R.
机构
[1] Univ Bologna, S Orsola Malpighi Hosp, Div Endocrinol, Dept Internal Med, I-40138 Bologna, Italy
[2] Univ Bologna, S Orsola Malpighi Hosp, Ctr Appl Biomed Res, I-40138 Bologna, Italy
[3] Univ Edinburgh, Endocrinol Unit, Ctr Cardiovasc Sci, Edinburgh EH8 9AG, Midlothian, Scotland
关键词
D O I
10.1210/jc.2005-2222
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Elevated adrenal androgen levels are common in polycystic ovary syndrome (PCOS), but the underlying pathogenetic mechanism is poorly understood. In the rare cortisone reductase deficiency, impaired regeneration of active cortisol from inert cortisone by 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1) results in compensatory activation of ACTH secretion and adrenal hyperandrogenism. 11 beta-HSD1 deficiency may protect against obesity and its metabolic consequences because of impaired regeneration of cortisol in adipose tissue. Objective: Our objective was to investigate a functional polymorphism in HSD11B1 (T -> G in the third intron rs12086634, which associates with lower 11 beta-HSD1 activity) in PCOS with and without obesity. Design and Setting: We conducted a case-control study in lean and obese PCOS patients and controls at an academic hospital. Participants: Participants included 102 Caucasian PCOS patients and 98 controls comparable for age, weight, and race. Main Outcome Measures: We assessed genotype distribution and influence of genotypes on clinical, hormonal, and metabolic parameters. Results: The G allele was significantly related to PCOS status (P = 0.041), and this association was mainly attributable to lean (P = 0.025), rather than obese (P = 0.424), PCOS patients. The G allele was associated with lower 0800-0830 h plasma cortisol (P < 0.001) and higher cortisol response to ACTH(1-24) (P < 0.001) in all women with PCOS and with higher dehydroepiandrosterone sulfate levels (P < 0.001), greater suppression of dehydroepiandrosterone sulfate by dexamethasone (P < 0.001), and lower fasting plasma low-density lipoprotein cholesterol (P = 0.002) levels in lean PCOS women. Conclusions: Genetic variation in 11 beta-HSD1 contributes to enhanced cortisol clearance and compensatory adrenal hyperandrogenism in lean patients with PCOS but may be protective against obesity and some features of the metabolic syndrome.
引用
收藏
页码:2295 / 2302
页数:8
相关论文
共 34 条
  • [1] Obesity and gender influence cortisol secretion and metabolism in man
    Andrew, R
    Phillips, DIW
    Walker, BR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (05) : 1806 - 1809
  • [2] Effects of the 11β-hydroxysteroid dehydrogrenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes
    Andrews, RC
    Rooyackers, O
    Walker, BR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) : 285 - 291
  • [3] Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome
    Apridonidze, T
    Essah, PA
    Iuorno, MJ
    Nestler, JE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) : 1929 - 1935
  • [4] Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency
    Draper, N
    Walker, EA
    Bujalska, IJ
    Tomlinson, JW
    Chalder, SM
    Arlt, W
    Lavery, GG
    Bedendo, O
    Ray, DW
    Laing, I
    Malunowicz, E
    White, PC
    Hewison, M
    Mason, PJ
    Connell, JM
    Shackleton, CHL
    Stewart, PM
    [J]. NATURE GENETICS, 2003, 34 (04) : 434 - 439
  • [5] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
    Fauser, BCJM
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. HUMAN REPRODUCTION, 2004, 19 (01) : 41 - 47
  • [6] CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
    FERRIMAN, D
    GALLWEY, JD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1961, 21 (11) : 1440 - +
  • [7] Interaction between an 11βHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians
    Franks, PW
    Knowler, WC
    Nair, S
    Koska, J
    Lee, YH
    Lindsay, RS
    Walker, BR
    Looker, HC
    Permana, PA
    Tataranni, PA
    Hanson, RL
    [J]. HYPERTENSION, 2004, 44 (05) : 681 - 688
  • [8] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [9] Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome - Phenotype and associated factors
    Gambineri, A
    Pelusi, C
    Manicardi, E
    Vicennati, V
    Cacciari, M
    Morselli-Labate, AM
    Pagotto, U
    Pasquali, R
    [J]. DIABETES, 2004, 53 (09) : 2353 - 2358
  • [10] Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome
    Gambineri, A
    Pelusi, C
    Genghini, S
    Morselli-Labate, AM
    Cacciari, M
    Pagotto, U
    Pasquali, R
    [J]. CLINICAL ENDOCRINOLOGY, 2004, 60 (02) : 241 - 249